CORCEPT THERAPEUTICS INC (CORT)
About CORCEPT THERAPEUTICS INC
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $761.4M
- Net income
- $99.7M
- Total assets
- $836.7M
- Market cap
- $10.2B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $10.2B
- Shares outstanding
- 117.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 14, 2004
Corcept Therapeutics Inc (CORT) Stock Price
- Profitable — net income of $99.7M in FY2025.
- Trading 29% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review CORCEPT THERAPEUTICS INC.
Write a review
News about CORCEPT THERAPEUTICS INC
News & sentiment via Polygon.io
Corcept Therapeutics Inc: frequently asked questions
Is Corcept Therapeutics Inc an American company?
Yes — Corcept Therapeutics Inc is an American company headquartered in Redwood City, California. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is Corcept Therapeutics Inc headquartered?
Corcept Therapeutics Inc is headquartered in Redwood City, California, United States.
Is Corcept Therapeutics Inc publicly traded?
Yes — Corcept Therapeutics Inc is a publicly traded company. Its stock trades under the ticker symbol CORT on the NASDAQ.
What does Corcept Therapeutics Inc do?
Corcept Therapeutics Inc is an American Pharmaceuticals company in the Health & Beauty sector.
